At Opticyte, we are committed to transforming the standard of care for the leading causes of organ failure, including sepsis. The problem is massive, is expensive to treat, and leads to one death every 2.8 seconds globally. Current technologies fail to provide clinicians with the definitive data they need to diagnose, monitor, and treat patients in real-time, when they have the best chance of preventing organ failure. Unlike existing oximeters, our VitalO₂ is accurate for people of all skin tones. Our VitalO₂ monitor is the first and only single solution to provide definitive, continuous, and actionable insights for these critical unmet needs. The FDA awarded Opticyte Breakthrough Device Designation on the strength of our clinical data and the promise of our technology to save lives. Opticyte's executive and advisory team includes pioneers in new optical spectroscopy and multivariate analysis technology, leaders in medical device commercialization, and medical clinicians. The company’s early funding successes, research validation, and product development milestones provide credibility and reinforce our position as a disruptive medical device innovator.
View Top Employees from OpticyteWebsite | http://www.opticyte.com |
Revenue | $600000 |
Employees | 8 (5 on RocketReach) |
Founded | 2016 |
Address | 4000 Mason Rd, Seattle, Washington 98195, US |
Phone | (206) 775-5525 |
Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
Industry | Retail, Medical Equipment Manufacturing, Medical Device, Health Care |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 334 Companies, NAICS Code 33 Companies |
Looking for a particular Opticyte employee's phone or email?
The Opticyte annual revenue was $600000 in 2024.
Stefan Kraemer is the Board Member of Opticyte.
5 people are employed at Opticyte.
Opticyte is based in Seattle, Washington.
The NAICS codes for Opticyte are [334, 33].
The SIC codes for Opticyte are [38, 384].